Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Brady

Showing results (221-230 of 412) with videos related to

Pageof 42
Sort By:
American Journal of Epidemiology|August 21, 2009
Effectiveness of mandatory alcohol testing programs in reducing alcohol involvement in fatal motor carrier crashesJoanne E Brady, Susan P Baker, Charles Dimaggio, et al.
The American Journal of Cardiology|February 8, 2005
Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial)Scott M Grundy, Gloria L Vega, Zhong Yuan, et al.
Gastroenterology|June 1, 1986
Urinary excretion of polyethylene glycol 3350 and sulfate after gut lavage with a polyethylene glycol electrolyte lavage solutionC E Brady, J A DiPalma, S G Morawski, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 6, 2007
Nationwide increase in the number of hospitalizations for illicit injection drug use-related infective endocarditisHannah L F Cooper, Joanne E Brady, Daniel Ciccarone, et al.
Journal of Vascular Surgery|April 1, 1997
A blinded trial of local recombinant tissue factor pathway inhibitor versus either local or systemic heparin in a vein bypass modelJ H Rapp, X M Pan, A Ghermay, et al.
Clinical Kidney Journal|October 30, 2020
Erratum: Frailty is independently associated with worse health-related quality of life in chronic kidney disease: a secondary analysis of the Frailty Assessment in Chronic Kidney Disease studyAndrew C Nixon, Theodoros M Bampouras, Neil Pendleton, et al.
ESC Heart Failure|December 17, 2021
N-terminal pro-B-type natriuretic peptide testing patterns in patients with heart failure with reduced ejection fractionJames L Januzzi, Xi Tan, Lingfeng Yang, et al.
Kidney360|September 5, 2023
Low-Dose Intravenous Methylprednisolone in Remission Induction Therapy for ANCA-Associated VasculitisLauren Floyd, Adam D Morris, Anamay Shetty, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 15, 2009
Induction pegylated interferon alfa-2b in combination with ribavirin in patients with genotypes 1 and 4 chronic hepatitis C: a prospective, randomized, multicenter, open-label studyDaniel E Brady, Dawn M Torres, Jong W An, et al.
Mayo Clinic Proceedings|May 13, 2005
A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: the ezetimibe add-on to statin for effectiveness (EASE) trialThomas A Pearson, Margo A Denke, Patrick E McBride, et al.
Pageof 42

Showing results (221-230 of 412) with videos related to

Sort By:
Pageof 42
American Journal of Epidemiology|August 21, 2009
Effectiveness of mandatory alcohol testing programs in reducing alcohol involvement in fatal motor carrier crashesJoanne E Brady, Susan P Baker, Charles Dimaggio, et al.
The American Journal of Cardiology|February 8, 2005
Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial)Scott M Grundy, Gloria L Vega, Zhong Yuan, et al.
Gastroenterology|June 1, 1986
Urinary excretion of polyethylene glycol 3350 and sulfate after gut lavage with a polyethylene glycol electrolyte lavage solutionC E Brady, J A DiPalma, S G Morawski, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 6, 2007
Nationwide increase in the number of hospitalizations for illicit injection drug use-related infective endocarditisHannah L F Cooper, Joanne E Brady, Daniel Ciccarone, et al.
Journal of Vascular Surgery|April 1, 1997
A blinded trial of local recombinant tissue factor pathway inhibitor versus either local or systemic heparin in a vein bypass modelJ H Rapp, X M Pan, A Ghermay, et al.
Clinical Kidney Journal|October 30, 2020
Erratum: Frailty is independently associated with worse health-related quality of life in chronic kidney disease: a secondary analysis of the Frailty Assessment in Chronic Kidney Disease studyAndrew C Nixon, Theodoros M Bampouras, Neil Pendleton, et al.
ESC Heart Failure|December 17, 2021
N-terminal pro-B-type natriuretic peptide testing patterns in patients with heart failure with reduced ejection fractionJames L Januzzi, Xi Tan, Lingfeng Yang, et al.
Kidney360|September 5, 2023
Low-Dose Intravenous Methylprednisolone in Remission Induction Therapy for ANCA-Associated VasculitisLauren Floyd, Adam D Morris, Anamay Shetty, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 15, 2009
Induction pegylated interferon alfa-2b in combination with ribavirin in patients with genotypes 1 and 4 chronic hepatitis C: a prospective, randomized, multicenter, open-label studyDaniel E Brady, Dawn M Torres, Jong W An, et al.
Mayo Clinic Proceedings|May 13, 2005
A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: the ezetimibe add-on to statin for effectiveness (EASE) trialThomas A Pearson, Margo A Denke, Patrick E McBride, et al.
Pageof 42